相关实验视频
Updated: Sep 20, 2025

06:51
A Patient-Derived Xenograft Model for Venous Malformation
Published on: June 15, 2020
5.5K
ангиопоетин-TIE2 输送回路促进了 PIK3CA 驱动的静脉形
Marle Kraft1, Hans Schoofs1, Milena Petkova1
1Uppsala University, Department of Immunology, Genetics and Pathology, Uppsala, Sweden.
Nature cardiovascular research
|May 23, 2025
概括
身体PIK3CA突变导致静脉形 (VMs). 这项研究确定了一个PI3K-FOXO1-ANGPT-TIE2信号电路驱动VM进展,揭示了TIE2作为这些血管异常的潜在治疗标.
科学领域:
- 血管生物学 血管生物学
- 分子遗传学 分子遗传学
- 癌症信号通路是癌症的信号通路.
背景情况:
- 静脉形 (VMs) 是一种常见的血管异常,缺乏有效的治疗方法.
- 身体PIK3CA突变经常通过激活PI3Kα-AKT-mTOR通路来驱动VM病原体.
研究的目的:
- 阐明了PIK3CA突变VM进展背后的特定信号机制.
- 确定VMs的新型治疗点.
主要方法:
- 使用PIK3CAH1047R驱动的VM鼠标模型.
- 进行单细胞转录组学和血统追踪.
- 研究的信号通路包括PI3K-AKT-mTOR,FOXO1和ANGPT-TIE2.2. 这些信号通路都在研究中.
主要成果:
- 确定了一个静脉特异性电路,PI3Kα过度激活会放大TIE2信号传输.
- 观察到突变内皮细胞与抑制的FOXO1和ANGPT2.2的克隆扩张.
- 证明TIE2或ANGPT抑制,但不是mTOR阻断,抑制了小鼠的VM生长.
- 在小鼠和人类VM中发现了TIE2活性增加的证据.
结论:
- 发现了一个PI3K-FOXO1-ANGPT-TIE2信号轴作为PIK3CA相关VM的关键驱动器.
- 突出了TIE2作为治疗静脉形的有希望的治疗标.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Mechanism of Angiogenesis
6.0K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.0K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Notch Signaling Pathway
4.5K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.5K

